ALNY
Alnylam Pharmaceuticals Inc.
$460.02
+$6.45(+1.42%)
70
Overall
40
Value
100
Tech
--
Quality
Market Cap
$59.45B
Volume
458.80K
52W Range
$205.87 - $484.21
Target Price
$465.67
EPS Estimates Overview
| Current Quarter | $0.59 | Next Quarter | $0.92 |
| Current Year | $0.84 | Next Year | $5.98 |
| QoQ Growth | +55.9% | YoY Growth | +611.9% |
| 3Y EPS CAGR | +32.9% | Target Price | $465.67 |
| Consensus | Buy | Upside | +1.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $460.02 | +1.4% | 458.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW